Showing 1 - 3 results of 3 for search 'Nashone A. Ray', query time: 0.02s Refine Results
  1. 1
    Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.

    Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy. by Shannon M Lenz, Jaymes H Collins, Nashone A Ray, Deanna A Hagge, Ramanuj Lahiri, Linda B Adams

    Published 2020-09-01
    Get full text
    Article
  2. 2
    IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy.

    IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy. by Deanna A Hagge, David M Scollard, Nashone A Ray, Vilma T Marks, Angelina T Deming, John S Spencer, Linda B Adams

    Published 2014-09-01
    Get full text
    Article
  3. 3
    Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy

    Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy by Shannon M. Lenz, Jaymes H. Collins, Nashone A. Ray, Deanna A. Hagge, Ramanuj Lahiri, Linda B. Adams, Susilene Maria Tonelli Nardi

    Published 2020-09-01
    Get full text
    Article

Search Tools: